Indantadol (hydrochloride)
Product Specifications
UNSPSC Description
Indantadol (CHF-3381) hydrochloride is a novel putative NMDA antagonist. Indantadol blocks the NMDA receptor in a dose-dependent and prevents cell damage[1].
Target Antigen
iGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/indantadol-hydrochloride.html
Smiles
O=C(CNC1CC2=C(C1)C=CC=C2)N.Cl
Molecular Weight
226.70
References & Citations
[1]Silvia Zucchini, et al. Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist. Neuroreport. 2022, 13, 6.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101440A/Indantadol-hydrochloride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101440A/
Clinical Information
Phase 2
CAS Number
202914-18-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1072629-01 0.02 mg (E-Coli)
Recombinant Bacillus anthracis Probable septum site-determining protein MinC (minC)
Ask
View Details 
MBS1072629-02 0.1 mg (E-Coli)
Recombinant Bacillus anthracis Probable septum site-determining protein MinC (minC)
Ask
View Details